Cargando…

Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?

INTRODUCTION: Two generic paediatric mortality scoring systems have been validated in the paediatric intensive care unit (PICU). Paediatric RISk of Mortality (PRISM) requires an observation period of 24 hours, and PRISM III measures severity at two time points (at 12 hours and 24 hours) after admiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Leteurtre, Stéphane, Leclerc, Francis, Wirth, Jessica, Noizet, Odile, Magnenant, Eric, Sadik, Ahmed, Fourier, Catherine, Cremer, Robin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522838/
https://www.ncbi.nlm.nih.gov/pubmed/15312217
http://dx.doi.org/10.1186/cc2869
_version_ 1782121858684944384
author Leteurtre, Stéphane
Leclerc, Francis
Wirth, Jessica
Noizet, Odile
Magnenant, Eric
Sadik, Ahmed
Fourier, Catherine
Cremer, Robin
author_facet Leteurtre, Stéphane
Leclerc, Francis
Wirth, Jessica
Noizet, Odile
Magnenant, Eric
Sadik, Ahmed
Fourier, Catherine
Cremer, Robin
author_sort Leteurtre, Stéphane
collection PubMed
description INTRODUCTION: Two generic paediatric mortality scoring systems have been validated in the paediatric intensive care unit (PICU). Paediatric RISk of Mortality (PRISM) requires an observation period of 24 hours, and PRISM III measures severity at two time points (at 12 hours and 24 hours) after admission, which represents a limitation for clinical trials that require earlier inclusion. The Paediatric Index of Mortality (PIM) is calculated 1 hour after admission but does not take into account the stabilization period following admission. To avoid these limitations, we chose to conduct assessments 4 hours after PICU admission. The aim of the present study was to validate PRISM, PRISM III and PIM at the time points for which they were developed, and to compare their accuracy in predicting mortality at those times with their accuracy at 4 hours. METHODS: All children admitted from June 1998 to May 2000 in one tertiary PICU were prospectively included. Data were collected to generate scores and predictions using PRISM, PRISM III and PIM. RESULTS: There were 802 consecutive admissions with 80 deaths. For the time points for which the scores were developed, observed and predicted mortality rates were significantly different for the three scores (P < 0.01) whereas all exhibited good discrimination (area under the receiver operating characteristic curve ≥0.83). At 4 hours after admission only the PIM had good calibration (P = 0.44), but all three scores exhibited good discrimination (area under the receiver operating characteristic curve ≥0.82). CONCLUSIONS: Among the three scores calculated at 4 hours after admission, all had good discriminatory capacity but only the PIM score was well calibrated. Further studies are required before the PIM score at 4 hours can be used as an inclusion criterion in clinical trials.
format Text
id pubmed-522838
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5228382004-10-17 Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials? Leteurtre, Stéphane Leclerc, Francis Wirth, Jessica Noizet, Odile Magnenant, Eric Sadik, Ahmed Fourier, Catherine Cremer, Robin Crit Care Research INTRODUCTION: Two generic paediatric mortality scoring systems have been validated in the paediatric intensive care unit (PICU). Paediatric RISk of Mortality (PRISM) requires an observation period of 24 hours, and PRISM III measures severity at two time points (at 12 hours and 24 hours) after admission, which represents a limitation for clinical trials that require earlier inclusion. The Paediatric Index of Mortality (PIM) is calculated 1 hour after admission but does not take into account the stabilization period following admission. To avoid these limitations, we chose to conduct assessments 4 hours after PICU admission. The aim of the present study was to validate PRISM, PRISM III and PIM at the time points for which they were developed, and to compare their accuracy in predicting mortality at those times with their accuracy at 4 hours. METHODS: All children admitted from June 1998 to May 2000 in one tertiary PICU were prospectively included. Data were collected to generate scores and predictions using PRISM, PRISM III and PIM. RESULTS: There were 802 consecutive admissions with 80 deaths. For the time points for which the scores were developed, observed and predicted mortality rates were significantly different for the three scores (P < 0.01) whereas all exhibited good discrimination (area under the receiver operating characteristic curve ≥0.83). At 4 hours after admission only the PIM had good calibration (P = 0.44), but all three scores exhibited good discrimination (area under the receiver operating characteristic curve ≥0.82). CONCLUSIONS: Among the three scores calculated at 4 hours after admission, all had good discriminatory capacity but only the PIM score was well calibrated. Further studies are required before the PIM score at 4 hours can be used as an inclusion criterion in clinical trials. BioMed Central 2004 2004-05-21 /pmc/articles/PMC522838/ /pubmed/15312217 http://dx.doi.org/10.1186/cc2869 Text en Copyright © 2004 Leteurtre et al.; Licensee Biomed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research
Leteurtre, Stéphane
Leclerc, Francis
Wirth, Jessica
Noizet, Odile
Magnenant, Eric
Sadik, Ahmed
Fourier, Catherine
Cremer, Robin
Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?
title Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?
title_full Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?
title_fullStr Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?
title_full_unstemmed Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?
title_short Can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?
title_sort can generic paediatric mortality scores calculated 4 hours after admission be used as inclusion criteria for clinical trials?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522838/
https://www.ncbi.nlm.nih.gov/pubmed/15312217
http://dx.doi.org/10.1186/cc2869
work_keys_str_mv AT leteurtrestephane cangenericpaediatricmortalityscorescalculated4hoursafteradmissionbeusedasinclusioncriteriaforclinicaltrials
AT leclercfrancis cangenericpaediatricmortalityscorescalculated4hoursafteradmissionbeusedasinclusioncriteriaforclinicaltrials
AT wirthjessica cangenericpaediatricmortalityscorescalculated4hoursafteradmissionbeusedasinclusioncriteriaforclinicaltrials
AT noizetodile cangenericpaediatricmortalityscorescalculated4hoursafteradmissionbeusedasinclusioncriteriaforclinicaltrials
AT magnenanteric cangenericpaediatricmortalityscorescalculated4hoursafteradmissionbeusedasinclusioncriteriaforclinicaltrials
AT sadikahmed cangenericpaediatricmortalityscorescalculated4hoursafteradmissionbeusedasinclusioncriteriaforclinicaltrials
AT fouriercatherine cangenericpaediatricmortalityscorescalculated4hoursafteradmissionbeusedasinclusioncriteriaforclinicaltrials
AT cremerrobin cangenericpaediatricmortalityscorescalculated4hoursafteradmissionbeusedasinclusioncriteriaforclinicaltrials